BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) a clinical-stage immunotherapy company driven to fight cancer and improve patients’ lives, announced that it has received approval...

To read the full story on AllPennyStocks.com, click here.

BriaCell Therapeutics (TSX:BCT)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more BriaCell Therapeutics Charts.
BriaCell Therapeutics (TSX:BCT)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more BriaCell Therapeutics Charts.